Literature DB >> 32856096

Autologous osteochondral transplantation for osteochondral lesions of the talus: high rate of return to play in the athletic population.

Dexter Seow1, Yoshiharu Shimozono1, Arianna L Gianakos2, Eugenio Chiarello3, Nathaniel Mercer1, Eoghan T Hurley1, John G Kennedy4.   

Abstract

PURPOSE: (1) To determine the rate of return to play following autologous osteochondral transplantation (AOT) for osteochondral lesions of the talus (OLT) and (2) report subsequent rehabilitation protocols.
METHODS: A systematic review of the PubMed, Embase, and The Cochrane Library databases was performed according to the PRISMA guidelines based on specific eligibility criteria. Return to play data was meta-analysed and subsequent rehabilitation protocols were summarised. Level of evidence and quality of evidence (Zaman's criteria) were also evaluated.
RESULTS: Nine studies that totalled 205 ankles were included for review. The mean follow-up was 44.4 ± 25.0 (range 16-84) months. The mean OLT size was 135.4 ± 56.4 mm2. The mean time to return to play was 5.8 ± 2.6 months. The mean rate of return to play was 86.3% (range 50-95.2%), with 81.8% of athletes returning to pre-injury status. Based on the fixed-effect model, the rate of return to play was 84.07%. Significant correlation was found between increase age and decrease rate of return to play (R2 = 0.362, p = 0.00056). There was no correlation between OLT sizes and rate of return to play (R2 = 0.140, p = 0.023). The most common time to ankle motion post-surgery was immediately and the most common time to full weight-bearing was 12 weeks.
CONCLUSIONS: This systematic review indicated a high rate of return to play following AOT in the athletic population. Size of OLT was not found to be a predictor of return to play, whereas advancing age was a predictor. Rehabilitation protocols were largely inconsistent and were primarily based on individual surgeon protocols. However, the included studies were of low level and quality of evidence. LEVEL OF EVIDENCE: Level IV.

Entities:  

Keywords:  Autograft; Osteochondral lesion; Rehabilitation protocol; Return to sport; Talus

Year:  2020        PMID: 32856096     DOI: 10.1007/s00167-020-06216-w

Source DB:  PubMed          Journal:  Knee Surg Sports Traumatol Arthrosc        ISSN: 0942-2056            Impact factor:   4.342


  1 in total

1.  Influence of basal support and early loading on bone cartilage healing in press-fitted osteochondral autografts.

Authors:  Tomasz L Nosewicz; Mikel L Reilingh; Martin Wolny; C Niek van Dijk; Georg N Duda; Hanna Schell
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2013-03-12       Impact factor: 4.342

  1 in total
  6 in total

1.  Recognition and Analysis of Sports on Mental Health Based on Deep Learning.

Authors:  LingSong Li; HaiXia Li
Journal:  Front Psychol       Date:  2022-06-15

2.  Results of the osteochondral autologous transplantation for treatment of osteochondral lesions of the talus with harvesting from the ipsilateral talar articular facets.

Authors:  Dong Dong Wan; Heng Huang; Mao Zhong Hu; Quan Yu Dong
Journal:  Int Orthop       Date:  2022-03-25       Impact factor: 3.479

3.  Effect analysis of iliac bone autografting for Hepple V osteochondral lesions of the talus.

Authors:  Xin Wang; Dong Zhang; Fengqi Zhang; Lin Jin; Donglin Shi; Zhiyong Hou
Journal:  J Orthop Surg Res       Date:  2022-01-15       Impact factor: 2.359

Review 4.  Treatment of non-traumatic avascular necrosis of the femoral head (Review).

Authors:  Ning Liu; Changming Zheng; Qinglong Wang; Zhipeng Huang
Journal:  Exp Ther Med       Date:  2022-03-10       Impact factor: 2.447

Review 5.  Effectiveness of Autograft and Allograft Transplants in Treating Athletic Patients With Osteochondral Lesions of the Talus.

Authors:  Jake Vogel; Varun Soti
Journal:  Cureus       Date:  2022-10-04

6.  Limited medial osteochondral lesions of the talus associated with chronic ankle instability do not impact the results of endoscopic modified Broström ligament repair.

Authors:  Shi-Ming Feng; Jie Chen; Chao Ma; Filippo Migliorini; Francesco Oliva; Nicola Maffulli
Journal:  J Orthop Surg Res       Date:  2022-02-03       Impact factor: 2.359

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.